Contract award
LEIDOS BIOMEDICAL RESEARCH INC
CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
- PIID
- 75N91019F00138
- Award key
- CONT_AWD_75N91019F00138_7529_75N91019D00024_7529
- Recipient UEI
- HV8BH9BPG8Y9
- Parent award
- CONT_IDV_75N91019D00024_7529
- Source as of
- —
Current award value
$30,072,4963
Obligated to date
$30,072,4962
Potential with options
$30,072,4963
- Awarding agency
- Department of Health and Human ServicesNational Institutes of Health
- Contractor
- LEIDOS BIOMEDICAL RESEARCH INC
- Place of performance
- Frederick, Maryland
- Set-aside
- None
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full and Open Competition
- Period of performance
- Sep 23, 2019 — Mar 31, 2031Through Mar 31, 2031 if all options are exercised
- Benchmark category
- Unclassified
Transaction history
Every action recorded against this award, in the order the government reported them.
| Mod | Action date | Reason | Obligation | Value at action |
|---|---|---|---|---|
| 0 | Sep 20, 2019 | Initial award | $3,561,763.00 | $30,072,495.87 |
| P00001 | Mar 5, 2021 | C | $218,703.00 | $30,072,495.87 |
| P00002 | May 27, 2021 | B | $7,268,296.00 | $30,072,495.87 |
| P00003 | May 18, 2022 | M | $414,862.00 | $30,072,495.87 |
| P00004 | Jun 28, 2022 | C | $1,284,221.00 | $30,072,495.87 |
| P00005 | Sep 11, 2023 | B | $1,777,461.00 | $30,072,495.87 |
| P00006 | Jun 7, 2024 | M | $0.00 | $30,072,495.87 |
| P00007 | Jul 18, 2024 | M | $0.00 | $30,072,495.87 |
| P00008 | Sep 19, 2024 | G | $5,077,161.00 | $30,072,495.87 |
| P00009 | May 2, 2025 | M | $0.00 | $30,072,495.87 |
| P00010 | Aug 26, 2025 | M | $2,014,484.00 | $30,072,495.87 |
| P00011 | Sep 17, 2025 | M | $2,478,621.00 | $30,072,495.87 |
| P00012 | May 19, 2026 | M | $0.00 | $30,072,495.87 |
| P00013 | Sep 17, 2026 | M | $4,167,482.00 | $30,072,495.87 |
| P00014 | Sep 23, 2026 | M | $1,809,441.87 | $30,072,495.87 |
Provenance
Which source record produced each displayed rollup figure.
| Field | Source | File | Retrieved | Parser | Artifact hash |
|---|---|---|---|---|---|
| awarding_agency_id | USAspending.gov | — | Sep 26, 2026 | usaspending_contract_csv@2026.08.2 | d57d0420e604 |
| contractor_id | USAspending.gov | — | Sep 26, 2026 | usaspending_contract_csv@2026.08.2 | d57d0420e604 |
| current_award_value | USAspending.gov | — | Sep 26, 2026 | usaspending_contract_csv@2026.08.2 | d57d0420e604 |
| naics_code | USAspending.gov | — | Sep 26, 2026 | usaspending_contract_csv@2026.08.2 | d57d0420e604 |
| potential_award_value | USAspending.gov | — | Sep 26, 2026 | usaspending_contract_csv@2026.08.2 | d57d0420e604 |
| psc_code | USAspending.gov | — | Sep 26, 2026 | usaspending_contract_csv@2026.08.2 | d57d0420e604 |
| total_obligated | USAspending.gov | — | Sep 26, 2026 | usaspending_contract_csv@2026.08.2 | d57d0420e604 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.
- 1Rollup values derive from 15 transaction records parsed from USAspending.gov, retrieved Sep 26, 2026 by transform awards@2026.08.1.
- 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
- 3Current and potential award values are taken from the latest reported action, not summed across modifications.